Rimo Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.29 M
- Revenue Growth 42.26%
- Profit Growth -42.66%
- Ebitda 833.26%
- Net Worth 53.12%
- Total Assets 4.99%
About Rimo Pharmaceuticals
Rimo Pharmaceuticals Private Limited (RPPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 April 2019 (Five years and ten months 0 days old ). Its registered office is in Kanakadasa Nagar, Karnataka.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.29 M.
Girish Basavaraju, Nandakumar Bhuvaneshwari, Bilaguli Divya, and One other member serve as directors at the Company.
Company Details
-
LocationKanakadasa Nagar, Karnataka
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U52609KA2019PTC123353
-
Company No.
123353
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Apr 2019
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Rimo Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Girish Basavaraju
|
Director | 10-Apr-2019 | Current |
|
Nandakumar Bhuvaneshwari
|
Director | 30-Dec-2023 | Current |
| Bilaguli Divya | Director | 30-Dec-2023 | Current |
|
Thuraganur Manjunath
|
Director | 10-Apr-2019 | Current |
Financial Performance of Rimo Pharmaceuticals.
Rimo Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 42.26% increase. The company also saw a substantial fall in profitability, with a 42.66% decrease in profit. The company's net worth Soared by an impressive increase of 53.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rimo Pharmaceuticals?
In 2021, Rimo Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Nectamed Laboratories LlpGirish Basavaraju and Thuraganur Manjunath are mutual person
-
Akihiro Pharmaceuticals Private Limited
Girish Basavaraju and Thuraganur Manjunath are mutual person
Charges (Loans)
₹5.29 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 0.43 Cr
- Karnataka Bank Ltd. : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Dec 2023 | Axis Bank Limited | ₹4.34 M | Open |
| 25 Jun 2022 | Karnataka Bank Ltd. | ₹0.95 M | Open |
How Many Employees Work at Rimo Pharmaceuticals?
Unlock and access historical data on people associated with Rimo Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rimo Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rimo Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.